# Processa Pharmaceuticals, Inc. (PCSA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PCSA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -13.89M | $ -14.45M | $ 0 | $ 5.58M |
| 2024 | $ 0 | $ -12.46M | $ -11.82M | $ 73.5K | $ 1.70M |
| 2023 | $ 0 | $ -12.03M | $ -8.72M | $ 150.6K | $ 4.99M |
| 2022 | $ 0 | $ -30.64M | $ -10.73M | $ 229.5K | $ 7.47M |
| 2021 | $ 0 | $ -13.58M | $ -10.36M | $ 78.5K | $ 25.49M |
| 2020 | $ 0 | $ -18.36M | $ -4.00M | $ 328.1K | $ 22.94M |
| 2019 | $ 0 | $ -4.33M | $ -3.55M | $ 1.03M | $ 8.01M |
| 2018 | $ 0 | $ -4.97M | $ -4.90M | $ 230.0K | $ 9.70M |
| 2017 | $ 0 | $ -2.50M | $ -2.23M | $ 2.45M | $ 373.2K |
| 2016 | $ 6.9K | $ -462.3K | $ -59.4K | $ 1.61M | $ -2.35M |
| 2015 | $ 159.3K | $ -4.71M | $ -1.23M | $ 1.37M | $ -1.98M |
| 2014 | $ 282.9K | $ -6.40M | $ -3.88M | $ 960.5K | $ 1.21M |
| 2013 | $ 444.4K | $ -4.36M | $ -3.65M | $ 776.6K | $ 1.67M |
| 2012 | $ 277.4K | $ -3.53M | $ -3.21M | $ 1.13M | $ 2.56M |
| 2011 | $ 14.7K | $ -881.5K | $ -1.04M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.40 |
| Current Ratio | 2.54 |

## Other views

- [Metrics](https://sponda.capital/en/PCSA.md)
- [Charts](https://sponda.capital/en/PCSA/charts.md)
- [Compare](https://sponda.capital/en/PCSA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.